S the impulse may come from DX side before or about the saje time as the expected April Battery developments...
"GeneoDX and Anteo begin commercial discussions with three, well established, Chinese IVD and POC companies and a local subsidiary of an internationally recognised Life Science group" Anteo 21Feb2019.
Life Science group?
J&J - Maybe via LSQ connections.
Merck - not sure AnteoCoat is applicable to their Shanghai CRISPR technology
GSK - Maybe, they dropoed Neuroscience from their Shanghai R&D lab & were to shift their focus onto Infectious Diseases & Public Health. Also Ellume connections.
As for POC/IVD Co's, Reviewing Shanghai GeneoDx's predecessor, Changchun Jienuo Medical Technology (CJMT) - shows they had some interesting connections, and Changchun 4th Uni appear to have done a lot of work on CLFA & LFIA tech.
Share Price, page-83
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $7.005K | 350.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 6136463 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 674070 | 3 |
View Market Depth
| Last trade - 10.03am 31/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |